Abbott and Google are linking continuous glucose monitoring data with Google’s AI-powered health coaching tools, giving the Gemini-powered service access to another source of personal health information.
Under a multiyear agreement, data from Abbott’s Lingo continuous glucose monitor will be integrated into the Google Health app. Users will be able to view glucose trends alongside information related to activity, sleep, and other wellness metrics.
Google Health Coach, which is built with Gemini, will use Lingo data alongside other health information to provide recommendations covering nutrition, activity, sleep, and recovery. Access to the AI coach requires a Google Health Premium subscription.
Google says Health Coach is not intended for medical purposes and warns that its AI responses can be inaccurate or incomplete. The company advises users to verify its responses and consult healthcare professionals when appropriate.
The Google Health app can also receive information from compatible wearables and third-party applications through Health Connect, Apple Health, and Google Health APIs.
The companies expect the Lingo integration to begin rolling out in the Google Health app later this year.
Lingo is an over-the-counter continuous glucose monitoring system designed for adults aged 18 and older who do not use insulin. The wearable tracks glucose levels throughout the day, while its accompanying app shows how factors including food, movement, and other daily activities correspond with changes in glucose.
According to FDA documents, Lingo continuously measures glucose in interstitial fluid rather than directly from blood. Its sensor is inserted under the skin on the back of the upper arm and uses an electrochemical process to measure glucose before transmitting the readings to the Lingo app through Bluetooth Low Energy.
The FDA says the Lingo app can display real-time glucose values, trend arrows, and glucose graphs. The sensor can be worn for up to 14 days, but the Lingo app does not provide glucose or system alerts.
The product is based on technology used in Abbott’s FreeStyle Libre platform. Abbott made Lingo available without a prescription in the US in 2024, and the system is also available in the UK.
FDA documentation also states that users should not take medical action based on Lingo readings without consulting a qualified healthcare professional.
Abbott and Google are also planning a large real-world study focused on metabolic health.